Tried and True
Express Scripts can sum up its overall strategy with a concept its CEO calls "Consumerology." The philosophy is based on the convergence of consumer behavior and healthcare.
Human beings don't behave rationally. From improving health outcomes to increasing medication adherence, pharmacy benefit leaders struggle to exert a positive influence over the improbable, impractical behavior of their members.
"We started thinking about why many people weren't acting rationally in their own self-interest," says George Paz, CEO and chairman of the board of Express Scripts. "We started pursuing applications of behavioral science and achieved some success. Soon we decided there was vast untapped potential for the strategy."
The PBM continues to study member behavior and decision-making, including how human emotions and the decision-making process itself affect choices. Express Scripts translates the behavioral information into strategies of influence for new benefit designs, products and services.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
ICI-Chemo Combo Delivers More Benefit Than Harm, Even for High-Risk NSCLC Patients, Study Finds
May 16th 2025Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the treatment of non-small cell lung cancer. But it is open question whether they should be combined with traditional chemotherapy.
Read More
